Thursday, February 9, 2012 Last update: 3:33 PM
The Best of U.S. Company Technology News
Now being accepted at FreshNews.com. See our complete guidelines.
AnaptysBio, Inc.
News articles for AnaptysBio, Inc.:
Friday, January 6, 2012
- AnaptysBio Announces New Strategic Antibody DiscoverySAN DIEGO, Jan. 6, 2012 /PRNewswire/ -- AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced the initiation of new strategic alliances with two partners: Novartis and an undisclosed second pharmaceutical company. The strategic alliance announced today with Novartis is AnaptysBio's second collaboration ... read more
Monday, December 5, 2011
- AnaptysBio Describes Technology for the Discovery and Optimization of Fully Human Antibodies in Original Research PublicationSAN DIEGO, Calif., Dec. 5, 2011 /PRNewswire/ -- AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced the publication of original research describing the discovery of novel fully-human antibodies against human nerve growth factor (NGF) using AnaptysBio's SHM-XEL(TM) platform in the Proceedings of the National Academy ... read more
Tuesday, October 11, 2011
- AnaptysBio Appoints Carol G. Gallagher as Executive Chair and Promotes Senior Leaders Hamza Suria and David J. KingAnaptysBio, Inc., a privately-held therapeutic antibody company, today announced that Carol G. Gallagher has joined its board of directors as Executive Chair. In addition, AnaptysBio has promoted Hamza ... read more
Thursday, September 29, 2011
- DARPA Extends Contract with AnaptysBio to Generate Additional High Affinity Thermally Stable AntibodiesAnaptysBio, Inc., a privately-held therapeutic antibody company, today announced that the Defense Advanced Research Projects Agency (DARPA) has extended its contract with AnaptysBio to generate additional high ... read more